Slightly more than half of all U.S. Representatives signed the Feb. 26 letter to HHS urging immediate action to stop drug manufacturers from making unilateral changes to 340B | Shutterstock

226 Bipartisan U.S. House Members Ask HHS to Stop Pharma From Unilaterally Changing 340B

Two hundred and twenty six U.S. House members—173 Democrats and 57 Republicans—have signed a letter to U.S. Health and Human Services (HHS) Acting Secretary Norris Cochran asking him “to take immediate action to ensure that manufacturers are prohibited from imposing unilateral changes to the program in direct conflict with congressional intent and decades of written guidance.” HHS Secretary-designate Xavier Becerra is copied on the letter.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
×

Sign up for news summaries and alerts from 340B Report